Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

Blood’s life history traced through genomic scars

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Nature 606, 255-256 (2022)

doi: https://doi.org/10.1038/d41586-022-01304-y

References

  1. Mitchell, E. et al. Nature 606, 343–350 (2022).

    Article  Google Scholar 

  2. Fabre, M. A. et al. Nature 606, 335–342 (2022).

    Article  Google Scholar 

  3. Jaiswal, S. et al. N. Engl. J. Med. 371, 2488–2498 (2014).

    PubMed  Article  Google Scholar 

  4. Vuckovic, D. et al. Cell 182, 1214–1231 (2020).

    PubMed  Article  Google Scholar 

  5. Chen, M.-H. et al. Cell 182, 1198–1213 (2020).

    PubMed  Article  Google Scholar 

  6. Bick, A. G. et al. Nature 586, 763–768 (2020).

    PubMed  Article  Google Scholar 

  7. Nam, A. S. et al. Nature 571, 355–360 (2019).

    PubMed  Article  Google Scholar 

  8. Bao, E. L. et al. Nature 586, 769–775 (2020).

    PubMed  Article  Google Scholar 

  9. Weinstock, J. S. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.12.10.471810 (2021).

Download references

Competing Interests

B.L.E. has received research funding from Celgene, Deerfield, Novartis and Calico, and consulting fees from GRAIL. He is a member of the scientific advisory board and shareholder for Neomorph Therapeutics, TenSixteen Bio, Skyhawk Therapeutics and Exo Therapeutics.

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links